Is Clinuvel Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Clinuvel Pharmaceuticals Ltd (CUV.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Clinuvel Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Clinuvel Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Clinuvel Pharmaceuticals Ltd?

Muslim investors may consider investing in Clinuvel Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Clinuvel Pharmaceuticals Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Clinuvel Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Clinuvel Pharmaceuticals Ltd updated?

The Shariah compliance status of Clinuvel Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Clinuvel Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Clinuvel Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Clinuvel Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CUV.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 13, 2025

Report Source: 2025 Annual Report

Analyst's Ratings for Clinuvel Pharmaceuticals Ltd (CUV.AX)

Based on 11 analysts giving stock ratings to Clinuvel Pharmaceuticals Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Clinuvel Pharmaceuticals Ltd. Stock Analysis CUV.AX

Australia Health Care Small Cap Report: 2025 Annual

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The company has operations in Europe, Singapore, and the United States of America. The company develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.

Key Statistics of Clinuvel Pharmaceuticals Ltd (CUV.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD9.40AUD9.60

Today's Open

AUD9.43

Volume

48.83K

P/E Ratio (TTM)

13.30

52 Week Range

AUD8.57AUD14.00

Market Cap

466.46M

Avg. Volume

9250.60

Dividend Yield

0.52%

Financial Metrics & Statements of Clinuvel Pharmaceuticals Ltd (CUV.AX)

FAQ's for Clinuvel Pharmaceuticals Ltd (CUV.AX)

According to Musaffa’s Shariah screening methodology, Clinuvel Pharmaceuticals Ltd (CUV.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.